Back to search

Article

Uptake of publicly-funded reproductive genetic carrier screening in Australia

2026-03-27

Abstract excerpt

<title>Abstract</title> <p>Reproductive genetic carrier screening (RGCS) for cystic fibrosis, spinal muscular atrophy and fragile X syndrome was added to Australia’s Medicare Benefits Scheme in November 2023. We analysed national uptake of publicly funded RGCS and compared testing volumes with birth numbers from November 2023 to August 2025. During this period, 206,321 patient tests and 7,554 partner tests were p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
037e640f-0678-54c6-8e08-be6ef28bbac3
DOI
10.21203/rs.3.rs-8537045/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Uptake of publicly-funded reproductive genetic carrier screening in AustraliaDOI 10.21203/rs.3.rs-8537045/v1
Select a neighboring publication to make it the new centre.